Multiple sclerosis and Lichenoid keratosis

Summary:

Lichenoid keratosis is found among people with Multiple sclerosis, especially for people who are female, 50-59 old.

The study analyzes which people have Lichenoid keratosis with Multiple sclerosis. It is created by eHealthMe based on reports of 23 people who have Multiple sclerosis from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

What is Multiple sclerosis?

Multiple sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath) is found to be associated with 1,088 drugs and 1,359 conditions by eHealthMe. Check the latest studies of Multiple sclerosis.

What is Lichenoid keratosis?

Lichenoid keratosis (a skin disorder described by rapid growing, reddish to brown, benign (noncancerous) lesion on the skin) is found to be associated with 279 drugs and 363 conditions by eHealthMe. Check the latest studies of Lichenoid keratosis.

On Jul, 20, 2026

23 people who have Multiple Sclerosis and Lichenoid Keratosis are studied.

Would you have Lichenoid keratosis when you have Multiple sclerosis?

Gender of people who have Multiple Sclerosis and experienced Lichenoid Keratosis *:

female: 86.36 %
male: 13.64 %

Age of people who have Multiple Sclerosis and experienced Lichenoid Keratosis *:

Common co-existing conditions for these people *:

Gait Disturbance: 2 people, 8.70%
Osteoporosis (bones weak and more likely to break): 1 person, 4.35%
Osteopenia (a condition where bone mineral density is lower than normal): 1 person, 4.35%
Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 1 person, 4.35%
Hypercalcaemia (elevated calcium (ca+) level in the blood): 1 person, 4.35%
Breast Cancer Metastatic: 1 person, 4.35%
Breast Cancer: 1 person, 4.35%

Common drugs taken by these people *:

Common symptoms for these people *:

Urinary Tract Infection: 8 people, 34.78%
Fatigue (feeling of tiredness): 8 people, 34.78%
Seborrhoeic Keratosis (noncancerous (benign) skin growths that some people develop as they age. they often appear on the back or chest): 7 people, 30.43%
Rashes (redness): 6 people, 26.09%
Stress And Anxiety: 6 people, 26.09%
High Blood Pressure: 5 people, 21.74%
Musculoskeletal Stiffness (stiffness of the body's muscles, joints, tendons, ligaments and nerves): 5 people, 21.74%
Balance Disorder: 5 people, 21.74%
Diarrhea: 5 people, 21.74%
Haemangioma (noncancerous, abnormally dense collections of dilated small blood vessels that may occur in the skin or internal organs): 5 people, 21.74%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Lichenoid keratosis?

- Check whether Lichenoid keratosis is associated with a drug or a condition

Related publications that referenced our studies

Christopher KL, Elner VM, Demirci H, "Conjunctival Lymphoma in a Patient on Fingolimod for Relapsing-Remitting Multiple Sclerosis", Ophthalmic Plastic & Reconstructive Surgery, 2017 May .
Christopher, K. L., Elner, V. M., & Demirci, H. , "Conjunctival lymphoma in a patient on fingolimod for relapsing-remitting multiple sclerosis", Ophthalmic plastic and reconstructive surgery , 2014 Jan .
Christopher KL, Elner VM, Demirci H, "Conjunctival Lymphoma in a Patient on Fingolimod for Relapsing-Remitting Multiple Sclerosis", Ophthalmic Plastic & Reconstructive Surgery, 2017 May .
Christopher, K. L., Elner, V. M., & Demirci, H. , "Conjunctival lymphoma in a patient on fingolimod for relapsing-remitting multiple sclerosis", Ophthalmic plastic and reconstructive surgery , 2014 Jan .

Related studies:

How the study uses the data?

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

The study is based on Lichenoid keratosis and Multiple sclerosis, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.